Circulating TGF-β1 and VEGF and risk of cancer among liver transplant recipients

Transplant recipients have elevated cancer risk, perhaps partly due to direct carcinogenic effects of immunosuppressive medications. Experimental evidence indicates that calcineurin inhibitors given to transplant recipients increase cellular expression of transforming growth factor β1 (TGF-β1) and v...

Descripción completa

Detalles Bibliográficos
Autores principales: Engels, Eric A, Jennings, Linda, Kemp, Troy J, Chaturvedi, Anil K, Pinto, Ligia A, Pfeiffer, Ruth M, Trotter, James F, Acker, Michelle, Onaca, Nicholas, Klintmalm, Goran B
Formato: Online Artículo Texto
Lenguaje:English
Publicado: John Wiley & Sons, Ltd 2015
Materias:
Clinical Cancer Research
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC4559036/
https://www.ncbi.nlm.nih.gov/pubmed/25919050
http://dx.doi.org/10.1002/cam4.455

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC4559036/
https://www.ncbi.nlm.nih.gov/pubmed/25919050
http://dx.doi.org/10.1002/cam4.455

Ejemplares similares